Kyphoplasty Market

Market Overview

The global Kyphoplasty Market was valued at approximately USD 963 million in 2024 and is projected to reach USD 1.75 billion by 2033, growing at a CAGR of 6.8% during the forecast period (2025–2033).

Kyphoplasty is a minimally invasive surgical technique used in the intervention of vertebral compression fractures (VCF) caused by osteoporosis, trauma, or malignancy. The technique involves creating space in the collapsed (fractured) vertebra through the intravertebral placement of a balloon, which then offers height restoration and injection of bone cement to stabilize the spine. Kyphoplasty can provide significantly reduced back pain through the restoration of alignment of the spinal column and release of pain-causing structures, and improved mobility. The market has shown strong growth related to increased incidence rates of osteoporosis, especially in the elderly, awareness of the use of minimally invasive techniques in spinal procedures, and advancement of balloon systems as well as bone cement formulations. In addition, a rise in outpatient spinal procedures combined with improved reimbursement rates have contributed to the uptake of kyphoplasty in developed countries. Cryptically, the high cost of the procedure as well as a risk of cement leakage should be evaluated in terms of overall evaluating how widely kyphoplasty is being adopted.

Market Dynamics

Market Drivers

Rising Incidence of Osteoporotic Vertebral Compression Fractures (VCFs)

The increase in the number of osteoporosis-related vertebral compression fractures (VCFs) is one of the driving forces behind the kyphoplasty market. Osteoporosis is a progressive bone disease caused by low bone mass and disruption of bone tissue that increases the chances of VCFs, particularly in older individuals.

According to the International Osteoporosis Foundation (IOF), osteoporosis contributes to over 8.9 million fractures every year, or an osteoporotic fracture every 3 seconds across the globe. Vertebral fractures are the most common type of osteoporotic fractures, accounting for approximately 1.4 million fractures each year.

As the population age, the number of osteoporosis cases continues to rise. The U.S. Centers for Disease Control and Prevention (CDC) reported in 2011 that 71 million Americans will be aged 65 and older (an age group that is prone to developing VCFs) by 2030. Given these circumstances, kyphoplasty has provided a useful, minimally invasive approach to not only decrease chronic back pain through vertebral stabilization, but other benefits also include restoring spinal deformation and movement of the spine.

In the clinical world, an emerging consensus on the use of kyphoplasty as an alternative to conventional approaches (bed rest + brace) is expanding due to quicker recovery and pain management outcomes. The number of osteoporotic patients continues to be an accelerating demand for kyphoplasty worldwide, particularly in Europe, North America, and East Asia (regions with aging populations).

Advancements in Minimally Invasive Spinal Surgery Techniques and Imaging Technologies

Rapid advancements in minimally invasive surgical (MIS) techniques and imaging technology are bringing enormous growth to the kyphoplasty market. Open surgeries are typically associated with longer recovery periods, higher risk of infection, and higher costs than minimally invasive procedures. Because kyphoplasty is a percutaneous and minimally invasive procedure, it has been shown to have shorter hospital stays, minimal blood loss, and lower post-surgical complications compared to open surgery.

Advances in imaging, such as fluoroscopy, intra-operative CT, and cone-beam CT, have allowed for improved accuracy of vertebral body access and cement placement compared to older techniques, and lower potential risk for surgeon exposure to radiation, cement leak, and nerve damage. The introduction of real-time 3D navigation and robotics in spinal surgery (e.g., Mazor X Stealth Edition by Medtronic and ExcelsiusGPS by Globus Medical) may allow surgeons to execute more accurate, robotic-assisted interventions, leading to a higher chance of success.

Additionally, there are advancements in bone cement materials as well, and both polymers and calcium phosphate-based cements have newer formulations that offer improved biocompatibility, mechanical strength, and precise setting time. Companies such as Stryker, Zimmer Biomet have developed newer ‘next-generation’ balloon kyphoplasty kits with updated advanced applicators, and lower radiation exposure to the surgeon provides additional efficiency to the procedure.

As hospitals and outpatient centers continue to integrate these tools to improve procedural outcomes and decrease recovery times, the demand for kyphoplasty will continue to increase—particularly for patients who value less invasive, quicker alternatives to spinal surgery.

Market Restraints

High Procedure Cost and Limited Reimbursement in Emerging Markets

The substantial cost of kyphoplasty, coupled with inconsistent or limited reimbursement policies (especially in low- and middle-income countries), is the most significant constraint on kyphoplasty markets. Kyphoplasty also requires complex surgical equipment along with imaging technologies and materials (bone cement), thus increasing the overall cost of kyphoplasty.

The average cost of a kyphoplasty procedure in the United States can range between USD 10,000 to USD 15,000 depending on the facility and insurance coverage. While most developed countries have comprehensive insurance systems where kyphoplasty is fully or partially covered, developing regions across the world are significantly different environments.

In many Asian, African and Latin American countries, there are very minimal or no reimbursements from public health insurances for spinal procedures (including kyphoplasty). Public health insurance schemes that exist often have kyphoplasty as an exclusion or with little or no reimbursed coverage making the financial burden almost unequivocally on the patient.

The World Bank reports that the share of out-of-pocket health expenditure is still over 40% of total health spending in many of those countries. In many developing countries, this kind of procedure is unaffordable to a reasonably large segment of the population. Thus, financial accessibility is necessary for kyphoplasty to be adopted in emerging markets where vertebral compression fractures are generally treated conservatively.

Segmental Analysis

The Kyphoplasty Market is segmented by product type and end-user. Each segment plays a vital role in enhancing patient recovery, minimizing surgical complications, and restoring vertebral integrity following compression fractures.

By Product Type

In 2024, the Instruments segment of the vertebral augmentation market generated the highest estimated revenue share of about 61.4% due to the need for these essential tools in the performance of balloon-assisted vertebral augmentation procedures. These tools include the bone cement applicators, inflatable bone tamps, guidewires, cannulas, and others that their use in restoring height to the vertebrae and preparing the cavity for the cement injection.

The rise of minimally invasive strategies in spinal surgeries alongside continuous improvements in ergonomic design and delivery precision has led to a higher demand for these instruments. The Bone cement is also expected to grow tremendously, especially with the development of polymethacrylate (PMMA) formulations that enhance the biocompatibility, thermal stability, and compressive strength of the polymerized cement.

The calcium phosphate-based cements are particularly popular because of their osteoconductive properties and potential over certain patient groups with diminished bone healing potential. With companies continuing to invest in next-generation bone fillers with tailored viscosity and a controlled polymerization process, this segment will continue to grow steadily throughout the forecast period.

By End-User

Hospitals lead the kyphoplasty space, representing approximately 58.7% of the market in 2024, as they are designed to deal with complex spinal procedures and provide follow up post operatively. Facilities such as large multi-specialty hospitals and trauma centers are more likely to invest in high-level imaging equipment and surgical navigation systems which make these hospitals a preferred site for kyphoplasty.

Additionally, hospitals can provide a larger number of qualified spine surgeons and anesthesiologists. ASCs are a quickly growing segment to the kyphoplasty market as they take on a less expensive outpatient approach. ASCs appeal to patients’ preference of preferring quicker recovery from spine surgery with less time in the hospital and have incorporated modern imaging equipment and a sophisticated surgical team to manage spinal procedures.

Specialty Clinics have emerged in developed countries, such as orthopedic and pain management clinics, due to their more focused services, streamlined processes, and patient-oriented care model. An increasing number of these clinics and their providers incorporate vertebroplasty into their treatment for elderly patients with osteoporosis related vertebral compression fractures.

Regional Analysis

North America

North America has the largest share in the kyphoplasty market with a share of 38.2% in 2024 due to the established healthcare system, the potential growth through high rates of osteoporosis disease, and the growing acceptance for minimally invasive spinal procedures.

The USA has the highest overall market because of the policies of reimbursement, high rates of healthcare spending and the existence of large companies such as Medtronic, Stryker, and Globus Medical. With more than 10 million Americans with osteoporosis, according to the National Osteoporosis Foundation, the incidence rate of vertebral compression fractures is huge, contributing particularly in the growth of the numbers of fracture procedures done.

The widespread use of advanced imaging and coordination of surgical guidance systems in the USA has also served to increase procedural volume. Canada follows closely behind with a strong public healthcare system that has partial coverage for kyphoplasty in some cases.

Europe

Europe constitutes the second largest market, represented by Germany, France, Italy, and the United Kingdom. In 2024, Europe attained 28.6% of revenue share globally attributed to older population, increasing knowledge of spine disorders, and improved healthcare delivery.

The European Society of Spine Surgeons and many other organizations continue to promote the early diagnosis and treatment of osteoporotic fractures, thus generating further adoption of procedures. The supportive government programs directed for elderly care, as well as the increases in spine specialty centers are furthering market growth.

Asia-Pacific

The Asia-Pacific market is expected to grow at the fastest compound annual growth rate (CAGR) at 8.1% from 2025 to 2033, aided by rapid population changes, increased urbanization and an increase in healthcare expenditures. Countries such as China, Japan, India and South Korea are experiencing rising numbers of vertebral fractures largely due to higher life expectancy and sedentary lifestyles.

Moreover, China and India are large untapped markets with growing middle-class populations that are prepared to increasingly spend money on expensive treatment options. Unfortunately, the access and reimbursement for kyphoplasty is still very limited in more rural districts.

Latin America and Middle East & Africa

Latin America has a relatively small but growing share of the kyphoplasty market. Brazil, Mexico, and Argentina are leading countries, which are benefiting from better healthcare infrastructure and an increased availability of spinal specialists. Access to high-cost procedures, and benefit limitations based on insurance and payers’ policies makes the widespread adoption of kyphoplasty improbable.

Public/private partnership initiatives and spending in private hospitals will eventually expand access to kyphoplasty in places like Brazil, Mexico, and Argentina. The Middle East Africa region is also the smallest share of the market but is developing momentum. The UAE and Saudi Arabia are the market leaders due to strong regional government health initiatives and increased investment in state-of-the-art surgical technologies.

Africa remains an underdeveloped market due to a lack of awareness, low healthcare funding, and a shortage of trained specialists. Nevertheless, growing medical tourism and patient demand for minimally invasive procedures represent opportunities for future growth.

Recent Development

1. February 2024 – Stryker Corporation launched the next-generation iVAS Elite balloon system, offering improved vertebral height restoration and cement delivery precision. The system integrates enhanced balloon control and radiopacity for better intraoperative visualization.
2. November 2023 – Medtronic plc introduced an upgraded version of its Kyphon™ Xpander II balloon kyphoplasty kit across key markets in North America and Europe. The kit features a lower-profile access cannula and improved cement viscosity controls, reducing procedure time and leakage risk.
3. August 2023 – Globus Medical Inc. announced the CE mark approval for its KYPHONEX™ system, a robotic-assisted kyphoplasty platform aimed at increasing surgical precision and reducing fluoroscopy exposure during vertebral augmentation.